Evaxion Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	15	19	41	85	-	-	Upgrade
Market Cap Growth	-73.04%	-53.98%	-51.46%	-	-	-	Upgrade
Enterprise Value	20	24	38	56	-6	-10	Upgrade
PE Ratio	-	-0.86	-1.78	-3.46	-	-	Upgrade
PS Ratio	207.17	259.63	-	-	-	-	Upgrade
PB Ratio	-4.01	-4.01	4.96	2.62	-	-	Upgrade
P/FCF Ratio	-1.07	-1.07	-1.58	-3.64	-	-	Upgrade
P/OCF Ratio	-1.07	-1.07	-1.60	-3.87	-	-	Upgrade
EV/Sales Ratio	279.60	332.05	-	-	-	-	Upgrade
EV/EBITDA Ratio	-1.14	-1.14	-1.71	-2.37	0.36	0.88	Upgrade
EV/EBIT Ratio	-1.14	-1.14	-1.71	-2.37	0.36	0.88	Upgrade
EV/FCF Ratio	-1.36	-1.36	-1.47	-2.42	0.46	1.35	Upgrade
Debt / Equity Ratio	-2.30	-2.30	1.24	0.11	0.00	0.00	Upgrade
Debt / EBITDA Ratio	-0.51	-0.51	-0.46	-0.16	0.00	0.00	Upgrade
Debt / FCF Ratio	-0.61	-0.61	-0.39	-0.16	0.00	-0.01	Upgrade
Quick Ratio	1.06	1.06	4.25	7.70	1.50	5.89	Upgrade
Current Ratio	1.18	1.18	4.51	8.03	2.22	6.36	Upgrade
Asset Turnover	0.00	0.00	0	0	0	0	Upgrade
Interest Coverage	-12.63	-12.63	-14.88	-26.01	-73.33	-8.84	Upgrade
Return on Equity (ROE)	-1238.10%	-1238.10%	-113.70%	-99.40%	-183.10%	-265.60%	Upgrade
Return on Assets (ROA)	-126.70%	-126.70%	-74.50%	-77.40%	-130.30%	-114.30%	Upgrade
Return on Capital (ROIC)	-361.46%	-361.46%	-136.14%	-71.51%	-234.74%	-115.59%	Upgrade
Earnings Yield	-146.29%	-116.74%	-56.25%	-28.91%	-	-	Upgrade
FCF Yield	-117.55%	-93.80%	-63.29%	-27.45%	-	-	Upgrade
Buyback Yield / Dilution	-19.12%	-19.12%	-20.86%	-1.32%	-	-	Upgrade
Total Shareholder Return	-19.12%	-19.12%	-20.86%	-1.32%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).